MetaTrader
  • Markets
  • Charts & Ideas
  • Algo
  • News
  • Store
  • Brokers
  • Download
  • Economic Calendar
  • Trading Signals
  • WebTerminal
  • Русский Русский
  • 中文 中文
  • Español Español
  • Português Português
  • 日本語 日本語
  • Deutsch Deutsch
  • 한국어 한국어
  • Français Français
  • Italiano Italiano
  • Türkçe Türkçe
Denali Therapeutics Inc. Common Stock

DNLI

#1306
Denali Therapeutics Inc. Common Stock
21.1800
+0.21%
Sector:
Base:
Profit Currency:
Daily Range
21.1800
21.1850
Year Range
13.7960
23.7700
Daily Change
+0.21%
Monthly Change
-1.17%
6 month change
+30.98%
Year Change
+30.98%
Previous Close
21.1350
Open
21.1850
Bid
Ask
Low
21.1800
High
21.1850
Volume
143
  1. Markets
  2. US Stock Market
  3. Healthcare
  4. DNLI
Open full chart

Financials

Overview Statement Statistics Dividends
Quarterly Annual
Value 202020212022202320242025 TTM

News

Zacks Zacks
SNY BIIB DNLI TAK
yesterday, 14:02
DNLI Q4 Loss Narrower Than Expected, Hunter Syndrome Drug in Focus
Investing Investing
DNLI
2026.02.24
Wolfe Research initiates Denali Therapeutics stock with Peerperform
Seeking Alpha Seeking Alpha
DNLI
2026.02.06
Denali Therapeutics Inc. (DNLI) Presents at 22nd Annual WORLDSymposium - Slideshow (NASDAQ:DNLI) 2026-02-06
Seeking Alpha Seeking Alpha
DNLI
2026.02.06
Denali Therapeutics Inc. (DNLI) Shareholder/Analyst Call Transcript
Seeking Alpha Seeking Alpha
DNLI
2026.02.05
Denali Therapeutics Inc. (DNLI) Shareholder/Analyst Call - Slideshow (NASDAQ:DNLI) 2026-02-05
Zacks Zacks
PCRX ZTS ACAD DNLI APLS
2026.02.03
5 Drug/Biotech Stocks Likely to Outperform Q4 Earnings Estimates
Investing Investing
DNLI
2026.01.29
Denali to present clinical data on rare disease therapies at WORLDSymposium
Investing Investing
DNLI
2026.01.15
Denali Therapeutics stock maintains Buy rating at Goldman Sachs on pipeline progress
Seeking Alpha Seeking Alpha
DNLI
2026.01.14
Denali Therapeutics Inc. (DNLI) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Zacks Zacks
SNY BIIB DNLI TAK
2026.01.07
Denali Therapeutics Unveils Portfolio Goals for 2026, Stock Up
Investing Investing
DNLI
2026.01.07
Denali Therapeutics stock rating initiated at Buy by UBS on Hunter syndrome drug potential
Investing Investing
DNLI
2026.01.06
Denali Therapeutics outlines key milestones for 2026

Markets

  • US Stock Market
  • Currencies
  • Cryptocurrencies
  • Metals
  • Commodities

Charts & Ideas

  • Trading Ideas
  • Education Ideas
  • Charts

MQL5 Community

  • Market
  • Signals
  • Forum
  • Articles
  • CodeBase

News

  • US Stock Market
  • Currencies
  • Cryptocurrencies
  • Metals
  • Commodities

Brokers

  • All Brokers
  • Forex
  • Stock
  • Metals
MetaTrader 5
MQL5 Channels
Economic Calendar
Disclaimer and Risk Disclosure Terms of Use Contacts and Requests Legal
Copyright 2000-2026, MetaQuotes Ltd